Merck pays nearly $1 billion to resolve Vioxx claims

    The Department of Justice announced yesterday that Merck, Sharp & Dohme will pay $950 million to resolve criminal and civil claims about Vioxx.

    Merck withdrew the drug in 2004, and as part of the agreement announced Wednesday, pleaded guilty to a violation of the Food, Drug and Cosmetic Act. The company was accused of making false statement’s about the drug’s cardiovascular safety.

    The resolution includes a $321 million criminal fine $628 million for the cardiovascular statements.

    • WHYY thanks our sponsors — become a WHYY sponsor

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    Together we can reach 100% of WHYY’s fiscal year goal